Engineered Natural Killer Cells Show Promise for Off-the-Shelf Cancer Immunotherapy
Originally Published 2 months ago — by ScienceAlert

Researchers from MIT and Harvard Medical School have developed engineered natural killer cells (CAR-NK) that can better target cancer cells, evade immune rejection, and reduce side effects, showing promising results in mice and lab tests, with potential for off-the-shelf cancer immunotherapy in humans.
